MDxHealth (MDXH) Non-Current Debt (2020 - 2026)
MDxHealth's (MDXH) quarterly Non-Current Debt came in at $35.3 million in Q1 2026, down 18.33% year-on-year from $43.3 million in Q1 2025, and up 36.96% quarter-over-quarter from $25.8 million in Q4 2025.
MDxHealth (MDXH) Non-Current Debt (2020 - 2026) Analysis & Trends
MDxHealth has disclosed Non-Current Debt across 7 years of filings, most recently posting $35.3 million for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $35.3 million, down 18.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.3 million (down 18.33% YoY), and the FY2025 annual result was $25.8 million, down 37.73% from the prior year.
- Non-Current Debt came in at $35.3 million for Q1 2026 at MDxHealth, up from $25.8 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $24.5 billion in Q2 2025 to a low of $25.4 million in Q3 2025.
- The 5-year median for Non-Current Debt is $43.3 million (2025), against an average of $1.7 billion.
- Peak annual rise in Non-Current Debt reached 60802.83% in 2025, while the deepest fall reached 38.65% in 2025.
- MDxHealth's Non-Current Debt stood at $53.5 million in 2022, then increased by 18.16% to $63.3 million in 2023, then plunged by 34.48% to $41.4 million in 2024, then tumbled by 37.73% to $25.8 million in 2025, then surged by 36.96% to $35.3 million in 2026.
- The last three Non-Current Debt figures came in at $35.3 million (Q1 2026), $25.8 million (Q4 2025), and $25.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.86 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 40.07 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 17.56 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 299.85 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 13.99 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 1.49 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.16 Bn |
| 10 | MDxHealth | 6,270.00 | -43.15 Mn | 16.61 Mn | 35.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.35 Mn |
| Mar 31, 2026 | 35.35 Mn |
| Dec 31, 2025 | 25.81 Mn |
| Dec 31, 2025 | 25.81 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Sep 30, 2025 | 25.44 Mn |
| Jun 30, 2025 | 24.51 Bn |
| Jun 30, 2025 | 24.51 Bn |
| Mar 31, 2025 | 43.28 Mn |
| Mar 31, 2025 | 43.28 Mn |
| Dec 31, 2024 | 41.45 Mn |
| Dec 31, 2024 | 41.45 Mn |
| Sep 30, 2024 | 41.46 Mn |
| Sep 30, 2024 | 41.46 Mn |
| Jun 30, 2024 | 40.25 Mn |
| Jun 30, 2024 | 40.25 Mn |
| Mar 31, 2024 | 64.88 Mn |
| Mar 31, 2024 | 64.88 Mn |
| Dec 31, 2023 | 63.26 Mn |
| Dec 31, 2023 | 63.26 Mn |